MedTrace Logo

EndoRings Colonoscopy for Adenoma Detection

NCT03469622 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2019-02-12

No results posted yet for this study

Summary

Adenoma detection rate (ADR) in colon cancer screening is most important for avoiding colon cancer development. Recent studies suggest a benefit of endoscopic devices attached to the distal tip of the colonoscope for improving the ADR. This work is the first GERMAN randomized controlled trial comparing standard colonoscopy with EndoRIngs-assisted colonoscopy.

EndoRings is a new FDA approved device that is attached to the distal tip of the colonoscope. Better Polyp detection is suspected by flattening the mucosal folds during withdrawal

Conditions

  • Adenoma

Interventions

DEVICE

EndoRings

EndoRings-assisted colonoscopy

DEVICE

Standard colonoscopy

Standard colonoscopy without any additional devices

Sponsors & Collaborators

  • Helios Albert-Schweitzer-Klinik Northeim

    lead OTHER

Principal Investigators

  • Tobias Meister, Prof. Dr. · HELIOS Albert-Schweitzer Klinik

  • Ralf Kiesslich, Prof. Dr. · HELIOS HSK Kliniken Wiesbaden

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-27
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03469622 on ClinicalTrials.gov